In Depth Analysis on Intragastric Balloon Market 2016-2024
Sellbyville, DE -- (SBWIRE) -- 11/19/2018 -- Global Intragastric Balloons Market was valued at USD 38.2 million in 2017 and is expected to witness more than 15.1% CAGR from 2018 to 2024.
The Intragastric Balloons Market to exceed USD 270 million by 2024; as per a new research report by Global Market Insights. Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved an effective non-surgical treatment option for obesity and other weight related disorders.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1173
Technological innovation coupled with reduced costs associated with treatment, short hospital stay and reduced recovery time will boost intragastric balloons market growth. Some of the factors such as erosion, damage to the esophagus, persistent nausea and vomiting and bacterial growth within the balloon may hamper demand in the coming years. The 2015 single intragastric balloons market share, was over 50% of global revenue, with more than 8% CAGR predicted, due to growing awareness coupled with increasing acceptance of non-invasive procedures. Saline filled balloons are set to witness over 9% CAGR, the ability to reduce weight and easy detection of deflation due to methylene blue should stimulate business growth
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Allurion Technologies
- Apollo Endosurgery
- MedicOne Medical Response
- Obalon Therapeutics
- Medsil - comércio e representação hospitalar
- Silimed Indústria de Implantes
U.S. market share held over 85% of regional revenue in 2015. According to OECD, obesity prevalence in U.S. accounts for 35% in 2014. Rising instances of obesity increases the risk of premature death from stroke, heart disease, gall bladder disease, type 2 diabetes and some cancers. Presence of established healthcare infrastructure coupled with favourable regulatory scenario should drive industry growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1173
Global Intragastric Balloons Market By Product
- Single Balloon
- Dual Balloon
- Triple Balloon
Global Intragastric Balloons Market By Filling Material
- Saline Solution
Global Intragastric Balloons Market By End-Use
- Ambulatory surgical centers